DCP3 Meeting on Economic Evaluation for Health: Cost-Effectiveness and Beyond



DCP3, in collaboration with the Harvard T.H. Chan School of Public Health and Priorities 2020 at the University of Bergen, hosted a two-day meeting on the extended cost-effectiveness analysis and benefit-cost analysis methods, on September 16-17 in Boston, MA.  The objectives of the meeting were: 

  • To inform development of the BCA and ECEA methods and conclusions chapters for the DCP3 and Priorities 2020 books.
  • To discuss the desirability (and perhaps means of finance) for development of BCA and ECEA reference cases to complement the reference case for CEA developed for the Bill & Melinda Gates Foundation.
  • To inform DCP3 authors who are undertaking BCAs or ECEAs as part of their chapters
  • To inform recalculation of the basic economics of GH2035.
  • To inform assessments of the economic consequences of major sources of disease.


Meeting materials:


Meeting participants engage in a discussion of how to account for non-health outcomes in economic evaluation.



Wednesday, September 16, 2015 to Thursday, September 17, 2015